Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $175,398 - $253,190
2,064 New
2,064 $233,000
Q2 2022

Aug 15, 2022

SELL
$67.99 - $132.89 $29,575 - $57,807
-435 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $40,924 - $56,636
435 New
435 $223,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Audent Global Asset Management, LLC Portfolio

Follow Audent Global Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Audent Global Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Audent Global Asset Management, LLC with notifications on news.